Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
US OPEN: Rebound on Wall Street despite higher Supercore inflation and a jump in yields
Oracle earnings: Good, but it could have been better.
Adobe Delivers Strong Results, but Falls Short of Expectations. The Market Fears the Impact of AI
Daily Summary: Indices Pull Back Under Pressure from Oil Prices